Method for inhibiting production of IgE by using IL-9 inhibitors
US5246701A · kind A · utility
22Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 13, 1991 |
| Grant date | Sep 21, 1993 |
| Priority date | — |
| Expiry date | Dec 13, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/805
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting production of IgE, and a method for enhancing production of IgG are taught. The methods are linked to the role of interleukin 9 in antibody production. Specifically, production of IgG is potentiated by administering either to a subject or a cell culture a combination of interleukin 4 and interleukin 9. Production of IgE is inhibited by administering an amount of an interleukin 9 inhibitor to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.